GLAXO.NS Forward P/E

The Forward P/E of GlaxoSmithKline Pharmaceuticals Ltd (GLAXO.NS) is 52.65.

Forward P/E estimates how much investors are willing to pay today for each dollar of a company's expected future earnings. It serves as a valuation tool based on projected profitability rather than past performance.

GLAXO.NS Forward P/E - Peers Comparison

Ticker	Name	Value
ALKEM.NS	Alkem Laboratories Ltd	28.36
LAURUSLABS.NS	Laurus Labs Ltd	57.34
JBCHEPHARM.NS	J B Chemicals and Pharmaceuticals Ltd	38.41
ORCHPHARMA.NS	Orchid Pharma Ltd	38.85
SANOFI.NS	Sanofi India Ltd	35.11
SHILPAMED.NS	Shilpa Medicare Ltd	53.75
IPCALAB.NS	IPCA Laboratories Ltd	39.31
APLLTD.NS	Alembic Pharmaceuticals Ltd	26.77
GRANULES.NS	Granules India Ltd	25.15
PGHL.NS	Procter & Gamble Health Ltd	36.06
SOLARA.NS	Solara Active Pharma Sciences Ltd	26.46
STAR.NS	Strides Pharma Science Ltd	16.46
GLAND.NS	Gland Pharma Ltd	31.91
AARTIDRUGS.NS	Aarti Drugs Ltd	12.15
SUVENPHAR.NS	Suven Pharmaceuticals Ltd	73.37
CAPLIPOINT.NS	Caplin Point Laboratories Ltd	31.07
ERIS.NS	Eris Lifesciences Ltd	52.86
ABBOTINDIA.NS	Abbott India Ltd	45.38
NATCOPHARM.NS	Natco Pharma Ltd	7.75
PFIZER.NS	Pfizer Ltd	33.54
AJANTPHARM.NS	Ajanta Pharma Ltd	35.27
IOLCP.NS	IOL Chemicals and Pharmaceuticals Ltd	17.13